Zymeworks (ZYME) News Today → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free ZYME Stock Alerts $8.26 +0.15 (+1.85%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineZymeworks (ZYME) Scheduled to Post Quarterly Earnings on Thursdayamericanbankingnews.com - April 25 at 2:32 AMZymeworks (NYSE:ZYME) Trading Up 3.5%americanbankingnews.com - April 21 at 3:12 AMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYMEprnewswire.com - April 20 at 12:15 PMZymeworks (NYSE:ZYME) Shares Up 3.5%marketbeat.com - April 19 at 12:24 PMBuy Zymeworks Pioneering Cancer Treatments: Zanidatamab's Promising Dataseekingalpha.com - April 18 at 6:22 PMLevi & Korsinsky Reminds Shareholders of an Investigation into Zymeworks Inc. (ZYME) Regarding Potential Securities Fraud Allegationsmarkets.businessinsider.com - April 16 at 6:55 PMMaintaining Hold on Zymeworks: ZW191’s Potential Amidst Competitive and Regulatory Hurdlesmarkets.businessinsider.com - April 12 at 6:42 PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYMEprnewswire.com - April 12 at 9:30 AMZymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024globenewswire.com - April 11 at 6:00 AMZymeworks (NYSE:ZYME) Trading Down 2.6%marketbeat.com - April 9 at 11:46 AMZymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meetingglobenewswire.com - April 8 at 6:00 AMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYMEprnewswire.com - April 4 at 6:18 PMKirby McInerney LLP Announces Investigation of Shareholder Claims Against Zymeworks Inc. (ZYME)morningstar.com - April 4 at 7:39 AMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYMEstockhouse.com - April 2 at 5:54 PMZymeworks (NYSE:ZYME) Stock Price Down 6.7%marketbeat.com - April 1 at 3:29 PMZymeworks Inc. (NYSE:ZYME) Shares Purchased by Wellington Management Group LLPmarketbeat.com - March 29 at 4:09 AMZymeworks Inc.: Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directorsfinanznachrichten.de - March 28 at 10:14 AMZymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directorsglobenewswire.com - March 28 at 6:00 AMZymeworks Announces Participation in Upcoming Investor Conferencesglobenewswire.com - March 27 at 6:00 AMAnalysts’ Top Healthcare Picks: Zymeworks (ZYME), 89bio (ETNB)markets.businessinsider.com - March 13 at 6:44 PMAQR Capital Management LLC Has $5.07 Million Stock Holdings in Zymeworks Inc. (NYSE:ZYME)marketbeat.com - March 13 at 4:31 AMBuy Rating Affirmed for Zymeworks Amid Positive HERIZON Study Outlook and Robust Commercial Prospects of Zanidatamabmarkets.businessinsider.com - March 12 at 10:02 AMHold Rating on Zymeworks Amidst Pipeline Adjustments and Clinical Validation Awaitedmarkets.businessinsider.com - March 11 at 9:13 AMNext-Gen Winners: 7 Tech Stocks Set to Dominate the Decadeinvestorplace.com - March 8 at 10:18 AMZymeworks Inc.: Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Resultsfinanznachrichten.de - March 7 at 7:35 PMZymeworks Inc. (NYSE:ZYME) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 7 at 7:35 PMZymeworks Inc (ZYME) Reports Financial Results for Q4 and Full Year 2023finance.yahoo.com - March 7 at 2:35 PMZYME Stock Earnings: Zymeworks Beats EPS, Beats Revenue for Q4 2023investorplace.com - March 7 at 12:02 AMZymeworks Inc. 2023 Q4 - Results - Earnings Call Presentationseekingalpha.com - March 6 at 11:17 PMZymeworks Q4 2023 Earnings Previewmsn.com - March 6 at 7:24 PMZymeworks Reports Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - March 6 at 4:09 PMRubric Capital Management LP Increases Holdings in Zymeworks Inc. (NYSE:ZYME)marketbeat.com - March 6 at 2:46 PMZymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meetingglobenewswire.com - March 5 at 4:30 PMZYME Apr 2024 7.500 callca.finance.yahoo.com - March 5 at 10:09 AMZYME Oct 2024 15.000 callca.finance.yahoo.com - March 5 at 10:09 AMZYME Mar 2024 20.000 callfinance.yahoo.com - March 5 at 12:17 AMZymeworks: A Strong Buy Amidst Zanidatamab's Promising Developmentsseekingalpha.com - March 5 at 12:16 AMZymeworks Inc. (NYSE:ZYME) Shares Sold by Deutsche Bank AGmarketbeat.com - March 4 at 4:34 AMZymeworks (NYSE:ZYME) Reaches New 12-Month High at $12.71marketbeat.com - February 27 at 10:44 AMZymeworks Announces Participation in Upcoming Investor Conferencesglobenewswire.com - February 27 at 6:00 AMAcadian Asset Management LLC Acquires 727,934 Shares of Zymeworks Inc. (NYSE:ZYME)marketbeat.com - February 24 at 6:45 AMZYME Apr 2024 10.000 putfinance.yahoo.com - February 22 at 9:02 PMZYME Jul 2024 7.500 putfinance.yahoo.com - February 22 at 9:02 PMShould Investors Get Jazzed Up About This Small-Cap Biotech?realmoney.thestreet.com - February 22 at 4:01 PMLast Call! 7 Small-Cap Stocks Ready to Explode in Valueinvestorplace.com - February 20 at 4:19 PMZYME Mar 2024 15.000 callfinance.yahoo.com - February 17 at 12:29 PMZymeworks (NYSE:ZYME) Sets New 1-Year High at $11.90marketbeat.com - February 16 at 2:56 PM7 Small-Cap Stocks With Significant Upside Potential in 2024investorplace.com - February 15 at 10:04 AMZymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Callfinance.yahoo.com - February 14 at 9:44 AMZymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Callglobenewswire.com - February 14 at 6:00 AM Get Zymeworks News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYME and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. ZYME Media Mentions By Week ZYME Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZYME News Sentiment▼0.250.32▲Average Medical News Sentiment ZYME News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZYME Articles This Week▼32▲ZYME Articles Average Week Get Zymeworks News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYME and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ORIC News LYEL News GHRS News WVE News SIGA News NUVB News CVAC News VERV News MLYS News PRAX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ZYME) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zymeworks Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
